News
Important Only
ReutersTue, Dec 23
BRP And Its Principal Shareholder Announce Closing Of Previously Announced Secondary Offering
ReutersTue, Dec 23
Wheels Up Advances Fleet Modernization Plan With Strategic Sale-Leaseback Transaction And Satellite Wi-Fi Milestone
ReutersTue, Dec 23
US Gold Corp. Announces $31.2 Million Private Placement
ReutersTue, Dec 23
Mulberry Industries, Ramaco Resources Announce The Entry Into A Non-Binding Memorandum Of Understanding
ReutersTue, Dec 23
JFB Construction Announces 119% Increase In Anticipated Q4 2025 Revenues As Compared With Q4 2024 Revenues
ReutersTue, Dec 23
Oppenheimer starts Spruce Biosciences with "outperform" rating on rare disease strength
Other
Wheels Up Advances Fleet Modernization Plan With Strategic Sale-Leaseback Transaction And Satellite Wi-Fi Milestone
Dec 23 (Reuters) - Wheels Up Experience Inc UP.N:WHEELS UP ADVANCES FLEET MODERNIZATION PLAN WITH STRATEGIC SALE-LEASEBACK TRANSACTION AND SATELLITE WI-FI MILESTONEWHEELS UP EXPERIENCE INC - SALE PRICE ABOUT $105 MILLION, $65 MILLION TO REPAY DEBTReuters
Tue, Dec 23
Other
Mulberry Industries, Ramaco Resources Announce The Entry Into A Non-Binding Memorandum Of Understanding
Dec 23 (Reuters) - Ramaco Resources Inc METC.O:MULBERRY INDUSTRIES, RAMACO RESOURCES ANNOUNCE THE ENTRY INTO A NON-BINDING MEMORANDUM OF UNDERSTANDING THAT AIMS TO STRENGTHEN DOMESTIC RARE EARTH & PERMANENT MAGNET SUPPLY CHAINReuters
Tue, Dec 23
Stocks
Oppenheimer starts Spruce Biosciences with "outperform" rating on rare disease strength
Oppenheimer initiates coverage on Spruce Biosciences SPRB.O with "outperform" rating and $283 PTPT implies 241.7% upside to stock's last closeBrokerage expects U.S. accelerated approval next year for SPRB's experimental drug tralesinidase alfa (TA-ERT) to treat Sanfilippo type B synd...Reuters
Tue, Dec 23
Other
Immuneering To Announce 12-Month Overall Survival Data From Phase 2A Clinical Trial Of Atebimetinib + mGnP
Dec 23 (Reuters) - Immuneering Corp IMRX.O:IMMUNEERING TO ANNOUNCE 12-MONTH OVERALL SURVIVAL DATA FROM PHASE 2A CLINICAL TRIAL OF ATEBIMETINIB + MGNP IN FIRST-LINE PANCREATIC CANCER PATIENTS ON JANUARY 7, 2026Reuters
Tue, Dec 23
Other
Cassava Announces Agreement To Settle Securities Class Action Litigation
Dec 23 (Reuters) - Cassava Sciences Inc SAVA.O:CASSAVA ANNOUNCES AGREEMENT TO SETTLE SECURITIES CLASS ACTION LITIGATIONCASSAVA SCIENCES INC: WILL PAY $31.25 MILLION FOR COMPLETE SETTLEMENT AND RELEASE OF ALL CLAIMSCASSAVA SCIENCES: TO RESOLVE LITIGATION FILED IN US DISTRICT COURT IN TEXASReuters
Tue, Dec 23
Other
The Generation Essentials Group First The Generation Essentials Group-Sponsored SPAC Announces Successful Closing Of $150 Million IPO
Dec 23 (Reuters) - Generation Essentials Group TGE.N:THE GENERATION ESSENTIALS GROUP: FIRST THE GENERATION ESSENTIALS GROUP-SPONSORED SPAC ANNOUNCES SUCCESSFUL CLOSING OF $150 MILLION IPOReuters
Tue, Dec 23
Other
Siriuspoint Announces Expansion Of IMG Services Following Acquisition Of Assist America
Dec 23 (Reuters) - Siriuspoint Ltd SPNT.N:SIRIUSPOINT ANNOUNCES EXPANSION OF IMG SERVICES FOLLOWING ACQUISITION OF ASSIST AMERICASIRIUSPOINT LTD - ACQUISITION ACCRETIVE TO RETURN ON EQUITY AND EPSReuters
Tue, Dec 23
Other
Reviva Pharmaceuticals Recover-2 Trial Projected To Cost About $60 Million
Dec 23 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O:REVIVA PHARMACEUTICALS: RECOVER-2 TRIAL PROJECTED TO COST ABOUT $60 MILLIONREVIVA PHARMACEUTICALS: MAY INITIATE PHASE 3 TRIAL OF BRILAROXAZINE FOR NEGATIVE SYMPTOMS OR BIPOLAR DISORDER IN Q2 2026REVIVA PHARMACEUTICALS: NEGATIVE SYMPTOMS/B...Reuters
Tue, Dec 23
Other
Taylor Morrison Home: Unit Enters Amendment And Restatement Agreement - SEC Filing
Dec 23 (Reuters) - Taylor Morrison Home Corp TMHC.N:TAYLOR MORRISON HOME CORP - UNIT ENTERS AMENDMENT AND RESTATEMENT AGREEMENT - SEC FILINGTAYLOR MORRISON HOME CORP - CREDIT AGREEMENT INCLUDES $1 BILLION REVOLVING LOAN FACILITY - SEC FILINGTAYLOR MORRISON HOME CORP - CREDIT AGREEMENT INCLUDES $400...Reuters
Tue, Dec 23
Other
Safe Pro Group Launches SPAI Ventures To Pursue Strategic Investments Supporting Defense, Reconstruction, And Humanitarian Missions
Dec 23 (Reuters) - Safe Pro Group Inc SPAI.O:SAFE PRO GROUP LAUNCHES SPAI VENTURES TO PURSUE STRATEGIC INVESTMENTS SUPPORTING DEFENSE, RECONSTRUCTION, AND HUMANITARIAN MISSIONSReuters
Tue, Dec 23
Cryptocurrencies
Buying pressure weakens across BTC, ETH as volume metrics show sustained declines
Buying pressure in the crypto market is weakening simultaneously in terms of price action, derivatives activity, and on-chain indicators. According to CryptoQuant’s analysis, Bitcoin is still struggling to sustain the $87,000-$90,000 level. According to analyst Mignolet, the slowdown in buying has been evident since late August, which kick-started a spell of declining futures volume, falling […]Cryptopolitan
Tue, Dec 23
